Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure.
Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, Zioga N, Kogias D, Natsi AM, Pelekoudas C, Satiridou E, Bakola SA, Papagoras C, Mitroulis I, Peichamperis P, Mikroulis D, Papadopoulos V, Skendros P, Ritis K.
Gavriilidis E, et al. Among authors: mikroulis d.
Clin Immunol. 2022 May;238:109016. doi: 10.1016/j.clim.2022.109016. Epub 2022 Apr 18.
Clin Immunol. 2022.
PMID: 35447311
Free PMC article.